MedCodeSearch
HCPCS Level II Current in October 2026

M1174

Patient received at least two doses of the herpes zoster recombinant vaccine (at least 28 days apart) on october 20, 2017, through the end of the measurement period

Release
October 2026
Effective
Official source (opens in a new tab)

Version History

How M1174 appears in each release imported from the official files, newest first.

  1. October 2026 Effective

    Current

    Patient received at least two doses of the herpes zoster recombinant vaccine (at least 28 days apart) on october 20, 2017, through the end of the measurement period

  2. July 2026 Effective

    Unchanged

    Patient received at least two doses of the herpes zoster recombinant vaccine (at least 28 days apart) on october 20, 2017, through the end of the measurement period

  3. April 2026 Effective

    Unchanged

    Patient received at least two doses of the herpes zoster recombinant vaccine (at least 28 days apart) on october 20, 2017, through the end of the measurement period

  4. January 2026 Effective

    Unchanged

    Patient received at least two doses of the herpes zoster recombinant vaccine (at least 28 days apart) on october 20, 2017, through the end of the measurement period

Data Source

Code information on this page is derived from the October 2026 HCPCS Level II files published by CMS.

Release
October 2026
Effective
Source file
october-2026-alpha-numeric-hcpcs-file.zip

Official HCPCS Level II source files (opens in a new tab)

MedCodeSearch is an independent reference service and is not affiliated with CMS, CDC, or the U.S. government.

Look up another code

Search ICD-10-CM, ICD-10-PCS and HCPCS Level II by code or description.